ACHP Responds to RFI on Exercise of March-In Rights
ACHP submitted a response to an RFI from the National Institute of Standards and Technology on the exercise of march-in rights.
ACHP submitted a response to an RFI from the National Institute of Standards and Technology on the exercise of march-in rights.
ACHP submitted a response to an RFI from Senator Bill Cassidy (R-LA) on access to cell and gene therapies.
When people with diabetes follow their prescribed medical regimens, they are at least 30 percent less likely to wind up in the emergency room and at least 24 percent less likely to be admitted into the hospital, according to a new report from ACHP.
ACHP presented its 2023 Legislative Champion awards for visionary leadership to expand access to high-quality health coverage and care to Senator Ron Wyden (D-OR) and Congressman Blake Moore (R-UT).
Transparency in the drug supply chain is desperately needed to deliver consumers the lowest cost and highest value prescription drugs.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.